Product Information
URO-PAIN 99.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1847 per EA under NDC 57237033021. Its NADAC has been published 112 times since Jul 3, 2024.
Strength
99.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033021
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENAZOPYRIDINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
12/6/2023
Price Statistics
The NADAC for URO-PAIN 99.5 MG TABLET has been published 112 times since Jul 3, 2024, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1847 per EA |
|---|---|
| All-time high | $0.2052 (Sep 11, 2024) |
| All-time low | $0.1730 (Sep 17, 2025) |
| 52-week high | $0.1971 |
| 52-week low | $0.1730 |
| Median price | $0.1821 |
| Average price | $0.1834 |
| Largest weekly change | +16.1% (Aug 21, 2024) |
| Weeks tracked | 112 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of URO-PAIN 99.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for URO-PAIN 99.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1847 per EA (NDC 57237033021), effective Aug 19, 2026.
How has the price of URO-PAIN 99.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for URO-PAIN 99.5 MG TABLET has declined 2.3%. It has been tracked across 112 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for URO-PAIN 99.5 MG TABLET?
Since Jul 3, 2024, the NADAC for URO-PAIN 99.5 MG TABLET has ranged from a low of $0.1730 (Sep 17, 2025) to a high of $0.2052 (Sep 11, 2024), with a median of $0.1821 per EA.
Are there cheaper alternatives to URO-PAIN 99.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as URO-PAIN 99.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures URO-PAIN 99.5 MG TABLET?
URO-PAIN 99.5 MG TABLET (NDC 57237033021) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.